Injectable Drug Delivery Market Size Worth USD 27.8 Billion, Globally, by 2028 at 8.8% CAGR – Injectable Drug Delivery Industry Report by Vantage Market Research WASHINGTON, July 18, 2022 (GLOBE NEWSWIRE) -- In recent years, the growing prevalence of chronic diseases and rise in the use of biological components is driving the Injectable Drug Delivery Market....

Neuronascent Receives FDA Rare Pediatric Drug Designation for NNI-351 Treatment for Fragile X Syndrome ROCKVILLE, Md., May 24, 2022 (GLOBE NEWSWIRE) -- Neuronascent Inc., a clinical-stage biopharmaceutical company discovering and developing neuron-generating therapies for rare developmental...

Actress Patricia Richardson and NORD Join Together to Make a Difference on Rare Disease Day DANBURY, CT--(Marketwired - Feb 25, 2014) - Millions of Americans will participate in events across the country on February 28 as part of the 6th annual U.S. Rare Disease Day. These activities are...

LaVoie Group Congratulates Rare Disease Day Participants Cambridge, MA, Feb. 27, 2013 (GLOBE NEWSWIRE) -- LaVoie Strategic Communications Group, Inc.  (LaVoie Group), a firm with a proven track record of building value for health science innovations...